Table 4.
Multiple factor analysis of the relationship between contrast-enhanced ultrasound quantitative parameters, expression levels of endothelin-1 and basic fibroblast growth factor, and hepatocellular carcinoma recurrence after ablation
| Parameters | β | SE | Wald | P-value | OR |
95%CI |
|
| Lower limit | Upper limit | ||||||
| Low level of tRT | -0.207 | 0.062 | 5.326 | 0.037 | 0.813 | 0.720 | 0.918 |
| Low level of tPI | -0.076 | 0.007 | 7.392 | 0.006 | 0.927 | 0.914 | 0.940 |
| Low level of tTTP | -0.312 | 0.008 | 5.892 | 0.019 | 0.732 | 0.721 | 0.744 |
| High level of bFGF | 0.071 | 0.029 | 4.872 | 0.011 | 1.074 | 1.015 | 1.137 |
| Low level of pRT | -0.091 | 0.091 | 5.322 | 0.137 | 0.913 | 0.764 | 1.091 |
| Low level of pTTP | -0.057 | 0.032 | 4.352 | 0.086 | 0.945 | 0.888 | 1.006 |
| Low level of t-pTTP | -0.066 | 0.042 | 4.892 | 0.136 | 0.936 | 0.862 | 1.016 |
| Low level of t-pPI | -0.013 | 0.032 | 3.842 | 0.187 | 0.987 | 0.927 | 1.051 |
| High level of ET-1 | 0.031 | 0.032 | 5.762 | 0.879 | 1.032 | 0.969 | 1.099 |
ET-1: Endothelin-1; bFGF: Basic fibroblast growth factor; tRT: Tumor rise time; tTTP: Tumor time to peak; pTTP: Parenchymal time to peak; tPI: Tumor peak intensity; p-tTTP: Parenchymal-tumor time to peak.